MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
MARIMED INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.06−0.00 (-3.39%)
Close on Oct 19, 2026
- Market cap
- $22.78M
- P/E (TTM)
- –
- Dividend yield
- –
MARIMED INC. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product sales - retail | $23.22M | $21.73M | – | $22.57M | $22.33M | $20.73M | – | $23.39M | $23.62M | $22.35M | – | $24.12M | 55.4% | +4.0% |
| Product sales - wholesale | $18.51M | $17.52M | $17.63M | $18.03M | $17.13M | $16.79M | $16.21M | $16.31M | $15.87M | $14.51M | $13.74M | $13.64M | 44.2% | +8.1% |
| Other revenue | $193.00K | $237.00K | – | $160.00K | $41.00K | $390.00K | – | $897.00K | $947.00K | $1.08M | – | $1.04M | 0.5% | +370.7% |
| Real estate rentals | – | – | – | – | – | – | – | $319.00K | $283.00K | $374.00K | – | $631.00K | – | – |
| Management fees | – | – | – | – | – | – | – | $189.00K | $161.00K | $437.00K | $620.00K | $37.00K | – | – |
| Supply procurement | – | – | – | – | – | – | – | $323.00K | $469.00K | $228.00K | $409.00K | $321.00K | – | – |
| Licensing fees | – | – | – | – | – | – | – | $66.00K | $34.00K | $43.00K | $38.00K | $47.00K | – | – |
| Product sales - retail | – | – | – | – | – | – | – | $39.69M | $39.49M | $36.85M | – | $37.76M | – | – |
By region
From the segment and revenue-disaggregation notes of Marimed's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.